Standpoint Research
http://www.standpointresearch.comStandpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive six-year track record of more than 300 recommendations.
View Older Stories View More Recent Stories
-
Standpoint Research Upgrades Zimmer Holdings (ZMH) to Buy; Headwinds Should Be More Than Offset By Solid Pipeline, New Products & Cost Cutting
-
Standpoint Research Upgrades Symantec (SYMC) to Buy
-
Standpoint Research Upgrades H & R Block (HRB) to Buy
-
Standpoint Research Upgrades Chevron (CVX) to Accumulate
-
Standpoint Research Starts Medtronic, Inc. (MDT) at Accumulate
-
Standpoint Research Starts Illinois Tool Works (ITW) at Accumulate
-
Standpoint Research Starts BlackRock (BLK) at Accumulate
-
Standpoint Research Upgrades Quest Diagnostics (DGX) to Buy
-
Standpoint Research Starts Oshkosh (OSK) at Buy
-
Standpoint Research Upgrades True Religion Apparel (TRLG) to Buy
-
Standpoint Research Upgrades Sabesp (SBS) to Buy
-
Standpoint Research Upgrades Crocs (CROX) to Buy
-
Standpoint Research Upgrades Archer Daniels Midland (ADM) to Buy
-
Standpoint Research Upgrades Intel (INTC) to Buy; Accumulate After Recent Dip
-
Standpoint Research Upgrades SAFEWAY (SWY) to Buy; Expect Sales To Continue To Gradually Improve
-
Standpoint Research Upgrades Jacobs Engineering (JEC) to Buy; Aggressive After Recent Dip in Price
-
Standpoint Research Upgrades Coventry Health Care (CVH) to Buy
-
Standpoint Research Upgrades Stryker (SYK) to Buy
-
Standpoint Research Upgrades Pfizer (PFE) to Buy
-
Standpoint Research Upgrades MetroPCS (PCS) to Buy
-
Standpoint Research Downgrades True Religion Apparel (TRLG) to Hold
-
Standpoint Upgrades WESCO (WCC) to Buy, Sets $65 Target
-
Standpoint Research Upgrades Adobe (ADBE) to Buy
-
Standpoint Research Downgrades Healthways (HWAY) to Hold; Valuation Call
-
Standpoint Research Downgrades ManTech (MANT) to Hold
-
Standpoint Research Cuts Intel (INTC) from Buy to Hold
-
Standpoint Research Downgrades Coventry Health Care (CVH) to Hold; Valuation Call
-
Standpoint Research Upgrades Gran Tierra Energy (GTE) to Buy; Time to Jump Back In
-
Standpoint Starts Triumph Group (TGI) at Buy
-
Standpoint Research Starts Citi (C) at Buy, $55 Price Target
-
Standpoint Research Downgrades Lockheed Martin (LMT) to Hold
-
Standpoint Research Upgrades Parker Drilling (PKD) to Buy
-
Standpoint Research Upgrades Western Digital Corp. (WDC) to Buy
-
Standpoint Research Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Buy
-
Standpoint Research Upgrades True Religion Apparel (TRLG) to Buy
-
Standpoint Research Starts Energizer (ENR) at Buy
-
Standpoint Research Upgrades City Holding (CHCO) to Buy
-
Standpoint Research Upgrades Gap, Inc. (GPS) to Buy
-
Standpoint Research Downgrades Sabesp (SBS) to Hold
-
Notable Analyst Rating Changes 06/02: (AFFX) (JNJ) (DV) Upgraded; (GIS) (ES) (SRE) Downgraded
-
Standpoint Research Upgrades Microsoft (MSFT) to Buy
-
Standpoint Research Downgrades Expedia (EXPE) to Hold
-
Standpoint Research Starts International Bancshares (IBOC) at Buy
-
Standpoint Research Upgrades Arch Coal Inc (ACI) to Buy
-
Standpoint Research Cuts Crocs (CROX) to Hold; Shares Fall Slightly
-
Standpoint Research Maintains a 'Buy' on Intel (INTC); Raises PT
-
Standpoint Research Starts Lam Research (LRCX) at Buy, $60 Price Target
-
Standpoint Research Downgrades True Religion Apparel (TRLG) to Hold
-
Standpoint Research Downgrades CVS Caremark (CVS) to Hold
-
Standpoint Research Downgrades Zimmer Holdings (ZMH) to Hold

